Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia.

MLA

Bartolomé-Nebreda, José Manuel, et al. “Discovery of a Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitor for the Potential Treatment of Schizophrenia.” Journal of Medicinal Chemistry, vol. 57, no. 10, May 2014, pp. 4196–212. EBSCOhost, https://doi.org/10.1021/jm500073h.

APA

Bartolomé-Nebreda, J. M., Delgado, F., Martín-Martín, M. L., Martínez-Viturro, C. M., Pastor, J., Tong, H. M., Iturrino, L., Macdonald, G. J., Sanderson, W., Megens, A., Langlois, X., Somers, M., Vanhoof, G., & Conde-Ceide, S. (2014). Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia. Journal of Medicinal Chemistry, 57(10), 4196–4212. https://doi.org/10.1021/jm500073h

Chicago

Bartolomé-Nebreda, José Manuel, Francisca Delgado, María Luz Martín-Martín, Carlos M Martínez-Viturro, Joaquín Pastor, Han Min Tong, Laura Iturrino, et al. 2014. “Discovery of a Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitor for the Potential Treatment of Schizophrenia.” Journal of Medicinal Chemistry 57 (10): 4196–4212. doi:10.1021/jm500073h.